Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonMark Ainsworth, Christopher J. Groves, Abbie Bown et al.|The Lancet Infectious Diseases|2020Cited by 405
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Helen Fryer, Koen B. Pouwels et al.|Nature Medicine|2022Cited by 268
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, David Bonsall, Philippa C. Matthews et al.|Nature Communications|2021Cited by 147
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|Cancer Research|2021Cited by 49
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug responsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 10